EXOCIN

This brand name is authorized in Spain, Finland, Ireland, Turkey, United Kingdom, South Africa

Active ingredients

The drug EXOCIN contains one active pharmaceutical ingredient (API):

1 Ofloxacin UNII A4P49JAZ9H - OFLOXACIN

Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. Read about Ofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EXOCIN Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AE01		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62560
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 573089
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142314, 161735, 36792
Country: IE	Health Products Regulatory Authority	Identifier(s): 24365
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561119
Country: ZA	Health Products Regulatory Authority	Identifier(s): Z/15.1/347